Agilent Technologies (A) Earning Somewhat Critical Press Coverage, Analysis Finds
Media coverage about Agilent Technologies (NYSE:A) has been trending somewhat negative recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Agilent Technologies earned a coverage optimism score of 0.00 on Accern’s scale. Accern also assigned news articles about the medical research company an impact score of 44.9788002608326 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the media stories that may have effected Accern’s analysis:
- Nebulizer Market Size Worth $1.3 Billion By 2025 | CAGR: 6.5%: Grand View Research, Inc. (prnewswire.co.uk)
- Agilent Awards Angiex with a Golden Ticket at LabCentral (finance.yahoo.com)
- Agilent Technologies Inc (A) Expected to Announce Quarterly Sales of $1.16 Billion (americanbankingnews.com)
- Nomadic sues Mystic Lake tribe over scuttled Super Bowl nightclub (finance.yahoo.com)
- Global Gas Chromatography Market Competitive Dynamics 2018: Agilent Technologies, Shimadzu Corporation, R. Grace & Co. Inc., Phenomenex (topexaminer.com)
Shares of Agilent Technologies (NYSE:A) opened at $74.90 on Monday. The company has a quick ratio of 2.85, a current ratio of 3.30 and a debt-to-equity ratio of 0.37. Agilent Technologies has a fifty-two week low of $47.38 and a fifty-two week high of $74.94. The firm has a market cap of $24,168.21, a PE ratio of 35.63, a PEG ratio of 2.26 and a beta of 1.28.
The company also recently announced a quarterly dividend, which was paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd were issued a $0.149 dividend. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. The ex-dividend date was Friday, December 29th. This represents a $0.60 annualized dividend and a dividend yield of 0.80%. Agilent Technologies’s dividend payout ratio is presently 28.57%.
A has been the topic of several analyst reports. Robert W. Baird reissued a “buy” rating and issued a $76.00 price target on shares of Agilent Technologies in a report on Thursday, January 18th. Barclays boosted their price target on shares of Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. JPMorgan Chase & Co. boosted their price target on shares of Agilent Technologies to $75.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. Deutsche Bank set a $75.00 price target on shares of Agilent Technologies and gave the company a “buy” rating in a report on Tuesday, November 21st. Finally, Cowen reissued a “hold” rating and issued a $70.00 price target on shares of Agilent Technologies in a report on Wednesday, November 22nd. Six analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $69.25.
In other Agilent Technologies news, insider Patrick Kaltenbach sold 7,358 shares of the company’s stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $69.28, for a total transaction of $509,762.24. Following the transaction, the insider now directly owns 72,862 shares in the company, valued at approximately $5,047,879.36. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Michael R. Mcmullen sold 22,481 shares of the company’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $68.77, for a total transaction of $1,546,018.37. Following the transaction, the chief executive officer now owns 336,637 shares in the company, valued at $23,150,526.49. The disclosure for this sale can be found here. In the last quarter, insiders have sold 198,141 shares of company stock worth $13,830,045.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.